Blood and cyst fluid study for pancreatic cyst conditions
Part of Cancer, Digestive system clinical trials.
This study looks for “biomarkers,” or measurable lab signals, in blood and (when available) cyst fluid to understand pancreatic cyst problems and related conditions. It may help doctors better predict what these conditions are and how to manage them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic cystic lesion, or acute pancreatitis, chronic pancreatitis, pancreatic cancer, or a rare congenital (born-with) pancreas condition.
- You may have one diagnosis or a combination of these.
- You can sign written consent to have extra blood drawn for research.
- If you have pancreatic cysts, you must be willing to consent to collection of any extra cyst fluid remaining after routine testing.
- If you are having surgery (for any of the listed pancreas conditions), you must consent to research use of any leftover surgical tissue specimen.
- You generally must not have another active cancer in a different organ (or a past history of such) and must be able to consent and return for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
This study collects blood and cystic fluid samples from people who are already scheduled for surgery to remove a worrisome pancreatic cyst. The goal is to learn more about these cysts and possibly improve future diagnosis and treatment.
This study looks at the genetic material (genomics) of pancreatic cysts to better understand them and possibly improve diagnosis or treatment. By studying fluid or tissue from your cyst, researchers hope to find markers that can help guide care.
This study looks for molecular (lab) signals that may show advanced or higher-risk changes in certain pancreatic cysts. It may help doctors better sort which cysts are more concerning and may need closer attention.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
Hear when a new Pancreatic Cystic Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.